Dr. Sunil Kumar Bajpai is professor of Chemistry in Govt. Science College, Jabalpur, (M.P.) India. He obtained his Ph.D. degree in chemistry in the year 1997. His research areas include polymers for site specific drug delivery, polymer/nanoparticles composites and bio-polymers for wound healing management. He is member of Editorial Boards in various international journals of high impact factors. He has been reviewer for a number of esteemed journals published by ACS, Elsevier, John Willey etc.. He has published 150 plus research papers in various research journals of international repute. He has authored various chapters in different books published by reputed publishing houses such as CRC press, Nova publishing, etc. He has also contributed a chapter in Encyclopedia on Polymers. He has completed a number of research projects funded by different national agencies. He also collaborated with a Swedish company TrioMed for fabrication of “Portable Dialysis Machine”.
Dr. Khalil is a Research Associate in the Department of Biochemistry and Molecular Genetics /Faculty of Medicine at the American University of Beirut. Her research interest is in the field of genetics and molecular oncology. Her studies mainly focus on the molecular signature of lung cancer, spanning the spectrum from basic to translational medicine and using multiple omics approaches. In parallel, Dr. Khalil has been actively involved in understanding the familial inheritance of several diseases such as congenital heart malformations and skin anomalies using next-generation sequencing technologies and bioinformatics. This background and expertise have helped in positioning Dr. Khalil as one of the leading personnel in COVID-19 research in Lebanon. Her studies aim at understanding the susceptibility and prognosis of SARS-CoV2 infection from a genetic perspective in this population.
Dr. Aman Rajpal have been actively involved in clinical research since 2011, starting as a research fellow at Mayo Clinic in Rochester, MN where he conducted insulin clamp studies in human subjects with type 2 diabetes. He is currently an Assistant Professor of Medicine at Case Western Reserve University (CWRU), Cleveland, Ohio and is involved in various academic activities for internal medicine residents and endocrinology fellows. He continues to do clinical research with a special focus on obesity, metabolic syndrome and type 2 diabetes. He is a PI for a project that aims to develop a novel tool that can help identify individuals at high risk for diabetes at an early stage, and it has been awarded a research grant by CWRU. He has recently published review articles on the effect of intermittent fasting in patients with metabolic syndrome and type 2 diabetes, and another one discussing the factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes.
Shiliang Song graduated from the Suzhou Medical College in 1983. From 1988 to 1992, he was the vice president of Huangjing Central Hospital of Taicang City. From 1997 to 2006, he was the director of emergency department of Taicang First Hospital affiliated to Soochow University. Now he is the chief physician and professor of internal medicine. Member of Suzhou Medical Technology Appraisal Expert Database. Jiangsu government procurement evaluation expert. He has published more than 20 papers. Hosted the project of “The Epidemiological Investigation and Prevention Strategy of Pesticide Poisoning in Taicang City” won the third prize of scientific and technological progress in Suzhou City. He was awarded a third-class merit by the Taicang Municipal People's Government and an excellent scientific and technological expert in Taicang City, China. He was also a key member of the 2003 fight against SARS. Since COVID-19 has been popular, He has fought in the first line of clinical practice and conducted in-depth research on the theory and practice of COVID-19 in his spare time. The paper "COVID-19 Is Further Subdivided Into COVIP-19 and COVII-19 " was published in Frontiers, Public Health, 16 June 2020 | https://doi.org/10.3389/fpubh.2020.00301 , and another paper "China Experience in Controlling COVID‐19 "was published in SocArXiv and OSF. http://dx.doi.org/10.31235/OSF.IO/GFNEP